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Abstract 
Background: The centrosome is a tiny organelle well-known for its 
role in establishing the bipolar spindle during cell division. Defects 
in centrosome function often give rise to human diseases 
including cancer and kidney cyst formation. We are interested in 
studying the function of one novel centrosomal protein named 
CEP78, identified in a proteomic screen for novel centrosomal 
components. Methods and results: Treatment of cells with 
nocodazole, a microtubule-depolymerizing agent that specifically 
depolymerizes cytoplasmic microtubules but not the stabilized 
centrosome microtubules, showed that CEP78 is a stable 
centrosomal component. Colocalization of this protein with other 
centrosomal markers such as CEP164, SAS6, Centrin, 
Polyglutamylated tubulin and POC5  at different phases of the cell 
cycle indicated that CEP78 specifically localizes to the distal end of 
the mother and daughter centrioles. There are 2 CEP78 dots 
during the interphase and as the cells go through mitosis, 
procentrioles mature, and the number of CEP78 dots increases to 
4 dots per cell and by the end of telophase each daughter cell has 
2 CEP78 dots. Characterization of CEP78 functional domains 
showed that Leucine-rich repeats are necessary for centrosomal  
localization of the protein. In addition, we found that 
overexpression of CEP78 did not change the number of centrioles 
and centrosomes but decreased the number and intensity of 
CEP170 dots (sub-distal appendage protein) without a decrease in 
the expression level of this protein. Further studies showed that 
there is no interaction between these 2 proteins. Finally, 
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overexpression of CEP78 protects microtubules from 
depolymerization in the presence of nocodazole, suggesting its  
ability to bind microtubules. Conclusion: Our findings suggest that 
CEP78 is targeted to the distal end of mature centrioles via its 
lecuine-rich repeats, where it could be involved in centriolar 
maturation or regulation of sub-distal appendage assembly 
and/or remodeling, a structure known to nucleate and anchor 
microtubules. Understanding the function of CEP78 will shed light 
on the role of the centrosome in cell cycle. 
Key words:  CEP78, Centrosome, CEP170, Microtubules 
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Resumé 
Contexte: Le centrosome est un petit organite bien connu pour 
son rôle dans l'établissement du fuseau bipolaire pendant la 
division cellulaire. Les déficiences de la fonction du centrosome 
donnent souvent lieu à des maladies humaines, y compris le 
cancer et la formation de kystes rénaux. Nous sommes intéressés 
à étudier la fonction d'une nouvelle protéine centrosomale 
nommée CEP78, identifiée dans un criblage protéomique pour de 
nouveaux composants centrosomaux. Méthodes et résultats : Le 
traitement des cellules avec le nocodazole, un agent qui 
dépolymérise spécifiquement les microtubules cytoplasmiques 
mais pas les microtubules stabilisés du centrosome, a montré que 
CEP78 est un composant centrosomal stable. La colocalisation de 
cette protéine avec d'autres marqueurs centrosomaux tels que 
CEP164, SAS6, Centrine, tubuline polyglutamylée et POC5, à 
différentes phases du cycle cellulaire a indiqué que CEP78 est 
précisément à l'extrémité distale des centrioles,  mères et  filles. Il 
eǆiste deuǆ poiŶts CEPϳϴ au Đours de l’iŶterphase et  les Đellules 
passent par la mitose, procentrioles maturent, et le nombre de 
points de CEP78  augmente à 4 par cellule et, à la fin de la 
télophase chaque cellule fille possède 2 points CEP78. La 
caractérisation des domaines fonctionnels de CEP78 a montré que 
des répétitions riches en leucine sont nécessaires pour la 
localisation centrosomale de la protéine. En outre, nous avons 
constaté que la surexpression de CEP78 ne change pas le nombre 
de mères/procentrioles mais diminue le nombre et l'intensité des 
points de CEP170 (protéine d'appendice sous-distal) sans 
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diminution du niveau d'expression de cette protéine. D'autres 
études ont montré qu'il n'y a pas d'interaction entre ces deux 
protéines. Enfin, la surexpression de CEP78 protège des 
microtubules contre la dépolymérisation en présence de 
nocodazole, ce qui suggère qu'il possède la capacité de lier les 
microtubules. Conclusion : Nos résultats suggèrent que CEP78 est 
destiné à l'extrémité distale des centrioles matures par ses 
répétitions riche en lecuine, où il pourrait être impliqué dans la 
maturation ou la régulation de l'assemblage ou de la rénovation 
de l'appendice sous-distal centriolaire, une structure connue dans 
la nucléation des microtubules et d'ancrage. Comprendre la 
fonction de Cep78 contribuera à éclaircir le rôle du centrosome 
dans le cycle cellulaire. 
Mots clés: CEP78, Centrosome, CEP170, Microtubules 
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Chapter 1 Introduction 
 
Cell cycle deregulation is a common feature of several cancers. 
This cycle is controlled by different pathways and organelles. Due 
to its microtubule nucleation ability and the role it plays in mitotic 
spindle assembly, centrosome is a key player in this regulation. 
Therefore, understanding the biology of centrosomes is key to 
better understanding of cell cycle. 
 
 
1.1 Centrosome structure 
 
The centrosome is a non-membranous organelle in the periphery 
of the nucleus during interphase (Fukasawa 2005, Schatten 2008). 
It consists of 2 centrioles (mother and daughter) embedded in an 
electron dense pericentriolar material (PCM) (Figure 1). The PCM 
contains proteins that regulate centrosome functions and is also 
involved in microtubule nucleation and anchoring (Dammermann, 
Muller-Reichert et al. 2004, Korzeniewski, Hohenfellner et al. 
2013). The centrioles are microtubule-based cylinders that are 
arranged orthogonally and are characterized by a 9-fold radial 
symmetry. The distal and proximal ends of centrioles have 
different functions. While the distal end of mother centriole is 
involved in ciliogenesis, its proximal end is the site of centriole 
duplication and that is where procentrioles, the centrioles in early 
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stage of development, start to form. Centrioles have polarity in 
terms of structure and composition and due to generational 
difference; the two centrioles are structurally and functionally 
different (Ou, Zhang et al. 2004, Kitagawa, Vakonakis et al. 2011, 
Bornens 2012). Structurally, the mother centriole carries two sets 
of appendages at the distal and sub-distal end. Two main distal 
appendage proteins include CEP164 and Odf2 and some 
important sub-distal appendage proteins are CEP170, Cenexin, 
Ninein, EB1 and ε-tubulin. Studies on sub-distal appendages 
indicate that these proteins are acquired during G1 and unlike 
distal appendages, disappear at the onset of mitosis 
(Guarguaglini, Duncan et al. 2005). Distal appendages are 
important for docking of the basal body to the cell membrane 
whereas sub-distal appendages participate in anchoring 
microtubules, endosome recycling and forming basal body, a 
structure at the base of cilia which promotes microtubule 
nucleation (Dammermann, Muller-Reichert et al. 2004, Tsang and 
Dynlacht 2013). Mother and daughter centrioles are also different 
functionally.  Although both centrioles can nucleate microtubules 
and accumulate PCM, microtubule anchoring is only done by 
mother centriole through its sub-distal appendages (Bornens 
2012). 
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Figure 1. The centrosome of human cells. Photo adapted from 
Bornens (Bornens 2012). 
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So far 500 proteins have been identified as centrosomal by mass 
speĐtrosĐopǇ. “oŵe of these proteiŶs suĐh as γ-tubulin are 
permanently associated with centrosome and remain in 
centrosome even after treatment with microtubule 
depolymerizing agents such as cold, nocodazole, colchicine 
derivatives. These proteins do not need microtubules for their 
centrosomal localization. However, some other centrosomal 
proteins such as Nuclear Mitotic Apparatus protein (NuMA) are 
cell-cycle-specific and temporarily associated with centrosome 
(Schatten 2008).  
Centriole biogenesis happens through two pathways,canonical 
and de novo. In the first and most common pathway, canonical, 
procentrioles form in association with the old centrioles whereas 
the de novo pathway is activated in the absence of centrioles and 
occurs in multiciliated cells. The second pathway is also thought 
to take place primarily at deuterosomes (Brito, Gouveia et al. 
2012). 
During centriole assembly, a disc of fibrous material forms first 
adjacent to the proximal end of the parental centriole. Next, a set 
of 9-fold symmetric spokes connected to a central axis form the 
cart wheel within this material. As the assembly of centriolar 
microtubules begins at the tips of the spokes, the structure 
elongates to form the mature centriole. Although in most dividing 
cells, mother and daughter centrioles template the formation of 
only one centriole per cell cycle, in ciliated tissues, up to 8 
centrioles can form simultaneously around the  parent centriole. 
During differentiation, multiciliated cells assemble multiple basal 
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bodies around structures of unknown composition called 
deuterosomes (Dammermann, Muller-Reichert et al. 2004, 
Azimzadeh and Marshall 2010, Korzeniewski, Hohenfellner et al. 
2013).     
 
 
1.2  Centrosomal proteins and their functions 
 
The centrosome is involved in cell shape, cell division, and 
transport of vesicles, cell polarity and motility through 
microtubule organization. Centrosomal proteins can be divided 
into 2 categories:  
1. “truĐtural proteiŶs suĐh as γ-tuďuliŶ, α-tuďliŶ, β-tublin, 
centrin, pericentrin, Ninein, C-Nap1, centriolin, CP110, 
cenexin, ODF2, CEP170 and PCM1 
2. Regulatory  molecules such as Cdc2, Cdk1, PLK1, Nek2 and 
Dynactin 
Due to the importance of the structural proteins, some of them 
are further discussed here.  
Gamma-tubulin: One well-studied structural centrosomal protein 
is Gamma-tubulin which is localized in PCM. This protein is 
conserved in eukaryotes and is a component of tubulin ring 
complex ;γ-TuRCͿ. γ-TuRC plays a role in microtubule nucleation 
by covering the minus ends of microtubules. This helps facilitate 
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the growth of protofilaments, the microtubule subunits (Schatten 
2008).  
Pericentrin: Another well-known centrosomal protein is 
pericentrin which forms a Đoŵpleǆ ǁith γ- tubulin and needs the 
motor protein dynein for its centrosome localization. This protein 
acts as a scaffold for anchoring numerous proteins and is essential 
for centrosome and spindle organization (Schatten 2008, Delaval 
and Doxsey 2010). 
Centrins: These proteins are conserved Ca2+ binding centrosomal 
proteins that are associated with centrioles and are important for 
centriole duplication (Schatten 2008). 
NuMA (Nuclear Mitotic Apparatus protein): NuMA is a regulatory 
centrosomal protein involved in the organization of mitotic 
apparatus during mitosis. It has microtubule binding capacity and 
converges spindle microtubule ends to poles. It also acts as 
nuclear matrix protein during interphase (Zeng 2000, Schatten 
2008)  
CEP170: This is a sub-distal appendage protein which gets 
phosphorylated by Polo-like kinase 1 (PLK1). It associates with 
spindle apparatus during mitosis. This protein has several 
microtubule binding domains and possibly plays a role in 
microtubule organization (Guarguaglini, Duncan et al. 2005).  
Ninein: This is another sub-distal appendage protein which acts as 
a doĐkiŶg site for γ-tubulin complex. It also participates in the 
anchorage of microtubule minus-ends (Moss, Bellett et al. 2007). 
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C-Nap1: C-Nap1 is important for centriolar cohesion and is 
regulated through phosphorylation by NEK2. It is involved in 
establishing link between the pair of basal bodies/centrioles 
through the protein rootletin which is a physical linker between 
the centrioles and binds to C-Nap1 (Yang, Adamian et al. 2006). 
CP110: This protein is a substrate of Cdk2 and is involved in 
centriole duplication. It also acts as a cap for the distal end of 
centrioles and in this way controls their length. Another important 
function of this protein is the negative modulation of cilia 
assembly through cooperation with CEP97 (Schmidt, Kleylein-
Sohn et al. 2009, Tsang and Dynlacht 2013).   
Centriolin: This centriolar protein localizes to the mother centriole 
and induces the assembly of primary cilia (Hinchcliffe 2003). 
CEP164:  This component of distal appendage is indispensable for 
primary cilia formation and localizes to the mother centriole 
(Graser, Stierhof et al. 2007). 
SAS6: SAS6 is one of the several proteins involved in the early 
stage of procentriole assembly and is essential for the nine-fold 
symmetry of the centriole (Nakazawa, Hiraki et al. 2007). 
POC5: This protein localizes to the distal end of the centrioles and 
is important for centriole elongation and hence full maturation of 
procentrioles (Azimzadeh, Hergert et al. 2009). 
The various functions of centrosomal proteins underline the 
importance of the centrosome in cellular function and the role it 
plays in regulation of several proteins. 
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1.3 Cell Cycle 
 
1.3.1 The cycle 
 
Cell cycle is a crucial cellular event which takes place in order to 
divide and duplicate cells. It consists of 2 distinct stages: 
interphase (G1, S and G2) and mitosis (prophase, metaphase, 
anaphase and telophase). The landmark of interphase is DNA 
replication which occurs during the S phase. G1 and G2 are the 
gap phases of interphase that prepare the cell for DNA synthesis 
and mitosis (Schafer 1998). Also, we must remember that 
sometimes cells enter a resting phase called G0 which means no 
proliferation and no DNA replication. Following  DNA synthesis in 
interphase, mitosis (M) begins during which the replicated 
chromosomes get segregated into two cells. The 4 phases of 
mitosis are prophase, metaphase, anaphase and telophase 
(Vermeulen, Van Bockstaele et al. 2003). During prophase, 
chromatin becomes condensed to form chromosomes and the  
nucleolus disappears. In early prometaphase, the nuclear 
membrane dissolves and kinetochores are formed around 
centromeres where microtubules attach to move the 
chromosomes. During metaphase, spindle fibers align the 
chromosomes ensuring that only one copy of each chromosome is 
received by each new nucleus. During anaphase, the paired 
chromosomes separate and move to opposite sides of the cell. 
Finally, during telophase new membrane surrounds the 
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chromatids at the opposite poles and chromosomes go back to 
their chromatin form. Following mitosis, the spindle fibers 
disperse and the cytokinesis begins. During this stage, actin 
contracts around the cell center and divides the cell into two new 
daughter cells. Cell division is controlled and regulated by 
different pathways and cell organelles including centrosomes 
(Morgan 2007). In the next section, these regulations will be 
further discussed. 
 
 
1.3.2   Control of cell cycle 
 
The control of cell cycle is vital for cell survival. The main players 
in the regulation of cell division are cyclin-dependent kinases 
(CDKs) which act by phosphorylating their target proteins. CDKs 
have a stable expression level throughout the cell cycle and are 
activated by cyclins required for different stages of cell cycle. 
During G1, CDK2 already activated by cyclin E, phosphorylates 
Histone H1.  This helps regulate the progression from G1 to S and 
is important for chromosome condensation and DNA replication. 
Next, cyclin A participates in both G2 and G2/M transition through 
the activation of CDK2 and CDK1. Furthermore, CDK4/CDK6/cyclin 
D phosphorylates Rb, which in turn release E2F, allowing E2F to 
activate transcription. Same is true for CDK2/ cyclin E. Finally, 
mitosis is regulated by CDK2 and cyclin B (Vermeulen, Van 
Bockstaele et al. 2003). In order for the cell cycle to progress 
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properly, there are several checkpoints which work through 
regulating the CDK activity. When there is a defect in DNA 
synthesis or chromosome segregation, the checkpoints become 
active and arrest the cell cycle for the repair to be done 
(Malumbres and Barbacid 2009).  
It seems that the events in the cell cycle are tightly coordinated 
with the centrosome cycle.  
 
 
1.3.3   Centrosome and cell cycle 
 
The centrosome has several functions during cell division. During 
interphase, it serves by nucleating microtubules, organizing 
cytoplasmic organelles and forming primary cilia. During mitosis, 
the centrosome plays an important role in bipolar spindle 
assembly and this is controlled by a checkpoint monitoring 
microtubule defects and their attachments to kinetochores 
(Schwartz and Shah 2005). 
For these functions, the centrosome cooperates with CDKs and 
cyclins. For instance it modulates G1 progression and entry into S 
phase through cyclins A/E. It has been shown that cyclin E has a 
centrosome localization signal (CLS) motif which is necessary to 
target cyclin E to the centrosome and controls the S phase 
initiation. Also, cyclin A binding to the centrosome might control 
the entry into S phase. Centrosome might control the interphase 
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through other pathways as well. For instance, studies have shown 
that removing the core centrosomal components such as 
centriolin, a mother centriole protein, delay cytokinesis and 
induces G1 arrest. Another example of such studies indicates that 
the overexpression of AKAP450, a PCM protein, induces 
cytokinesis defect and G1 arrest through p53 or p38. Finally, 
G2/M transition could be arrested by disruption of the interaction 
ďetǁeeŶ γ-TuďuliŶ riŶg Đoŵpleǆes ;γ-TuRCs) and pericentrin 
which anchors this complex at centrosomes. These findings imply 
the significance of centrosomes in the regulation of interphase 
events during the cell cycle (Matsumoto and Maller 2004, Doxsey, 
McCollum et al. 2005, Sluder 2005, Loffler, Lukas et al. 2006). 
Centrosome can also regulate mitosis. During prophase of mitosis, 
the activation of cyclinB/CDK1 occurs in centrosome. Also, the 
activation of cyclinB/CDK2 by cdc25 is centrosomal dependent. 
First, cdc25 gets phosphorylated by Aurora-A which localizes to 
centrosome during mitosis and then the activated cdc25 removes 
the inhibitory phosphate residues from CDK2 to control mitotic 
progression. Furthermore, the centrosome participates in DNA 
damage repair. This is done through negatively regulating cdc25 
by Chk1 which accumulates at centrosomes in response to the 
DNA damage caused by ultraviolet radiation or Hydroxyurea 
treatment (Doxsey, McCollum et al. 2005, Sluder 2005, Loffler, 
Lukas et al. 2006). 
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1.4 Centrosome Cycle 
 
Centrosomes need to be duplicated and segregated in synchrony 
with chromosomes. There are four phases in centrosome cycle: 
centriole disengagement, centriole duplication, centriole 
maturation and centriole separation. In summary, at the end of 
mitosis, the two centrioles of each centrosome disengage but 
remain in close proximity. During S phase, each centriole 
nucleates a procentriole along its wall, and in G2 phase, the 
centriole pairs accumulate more PCM required for microtubule 
nucleation and anchoring to mature into two centrosomes 
required for mitosis (Figure 2).  
 
a.   Centriole disengagement 
This phase starts in prophase and ends at the end of telophase. 
During centriole disengagement, the tight orthogonal positioning 
of the two centrioles in each centrosome pair is released and they 
move to a near parallel position. This stage is mainly controlled by 
PLK1 and Separase. First, PLK1 promotes the removal of Cohesin 
from centrosomes. Next, Separase cleaves Cohesin at the 
centriole to complete this process. Centriole disengagement is 
important for centriole duplication and for limiting it to once per 
cell cycle (Azimzadeh, Hergert et al. 2009, Bettencourt-Dias, 
Hildebrandt et al. 2011, Nigg and Stearns 2011, Korzeniewski, 
Hohenfellner et al. 2013). 
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b. Centriole duplication 
Since each daughter cell inherits one centrosome upon 
cytokinesis, it is essential that the centrosome duplicates before 
mitosis so that it can establish bipolarity and correct mitotic 
spindles. Centriole duplication starts early G1 and continues till 
G2. During this phase, PLK4 is first recruited to the wall of the 
mother and daughter centrioles by CEP152. The recruited PLK4 
then phosphorylates E3-ubiquitin ligase which in turn stabilizes its 
substrate SAS-6. Finally, SAS-6 plus SCL-interrupting locus protein 
(STIL) and CEP135 form a cartwheel that helps define the centriole 
nine-fold symmetry of procentrioles (Azimzadeh, Hergert et al. 
2009, Bettencourt-Dias, Hildebrandt et al. 2011, Nigg and Stearns 
2011, Korzeniewski, Hohenfellner et al. 2013). 
 
c. Centriole elongation and maturation 
The new formed procentrioles elongate during S and G2 phase.  
SAS-4 promotes this process and CP110 acts as a cap for the distal 
end of centrioles to limit microtubule extension. The proteins 
POC5, OFD1, CEP120 and SPICE1 help this process as well. 
Following the elongation, the daughter centriole acquires distal 
and sub-distal appendage components such as Ninein, CEP170 
and ODF2 and becomes fully mature. This phase is called 
maturation and is important for microtubule anchoring and 
ciliogenesis. Mature centrioles also accumulate more PCM 
proteins such as CEP152 and CEP192 which are involved in the 
recruitment of centriole duplication factors. CEP215 is also the 
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PCM protein essential for PCM assembly in the maturation 
process. Another important event of this stage is the significant 
increase of  microtubule nucleation activity in centrosomes due to 
the proteins Aurora A and PLK1. For this, PLK1 first recruits Aurora 
A  to the centrosome which co-loĐalizes ǁith γ-tubulin and then 
this protein in turn recruits the proteins necessary  for 
microtubule stabilization, such as NDEL1 (Azimzadeh, Hergert et 
al. 2009, Bettencourt-Dias, Hildebrandt et al. 2011, Nigg and 
Stearns 2011, Korzeniewski, Hohenfellner et al. 2013). 
 
d. Centriole separation 
During most of the cell cycle, the mother and daughter centrioles 
are connected to each other by Rootletin and C-Nap1, the 
components of the centrosomal linker. This link needs to be 
broken at the G2/M transition so the two new centrosomes can 
separate and move to the opposite sides of the cell and form the 
bipolar mitotic spindles. The proteins participating in this process 
are NEK2A, MST1/2, PLK1 and Eg5. First, MST1/2 kinases 
phosphorylates the protein kinase NEK2A which in turn 
phosphorylates C-Nap1 and rootletin to promote centrosome 
separation. Eg5 compliments this process by compensating for 
NEK2A activity if reduced and its recruitment to centrosome is 
done by PLK1 phosphorylation (Azimzadeh, Hergert et al. 2009, 
Bettencourt-Dias, Hildebrandt et al. 2011, Nigg and Stearns 2011, 
Korzeniewski, Hohenfellner et al. 2013). 
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Figure 2. The centrosome cycle. Photo adapted from Mardin et al 
(Mardin and Schiebel 2012). 
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1.5 Cilia 
 
Although eukaryotic cilia are conserved, they come in different 
sizes and functional roles (Quarmby and Parker 2005) . These 
structures are centriole-derived protrusions on the cell surface 
that contain microtubules and consist of axoneme and basal body. 
Axoneme is the microtubule structure of cilium and grows from 
ciliary basal body. Basal body which is at the base of eukaryotic 
cilia, is the same as mother centriole and participates in axoneme 
assembly (Bettencourt-Dias and Glover 2007). Similar to centriolar 
ŵiĐrotuďules, aǆoŶeŵe ŵiĐrotuďules are ŵade of αβ tuďuliŶ 
heterodimers and are surrounded by ciliary membrane which is 
different from the cell membrane.  There are 2 types of Cilia: 1. 
Primary or non-motile cilia which consist of 9 doublet 
microtubules and lack molecular motors. These cilia are usually 
one per cell and are specialized sensory structures. 2. Motile cilia  
which consist of 9 doublet microtubules surrounding a central pair 
of singlet microtubules and may be several hundred per cell 
(figure 3). These cilia need the motor protein dynein for their 
motility (Satir and Christensen 2007).  
Cilia grow at their distal tips and motor proteins transport ciliary 
precursors for assembly and maintenance (Quarmby and Parker 
2005). Signaling molecules, receptors and tubulins are 
transported to primary cilia by intraflagellar transport (IFT) and 
motor proteins such as dynein and kinesin-2 (Tsang, Bossard et al. 
2008). Since cilia do not have protein synthesis machinery, they 
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depend on IFTs for their assembly. IFTs perform in 2 directions 
due to the protein complexes, IFT-A and IFT-B. IFT-A is involved in 
both anterograde and retrograde transport of molecules, whereas 
IFT-B is only involved in transport from cell body to cilia and 
directs anterograde transport (Tsang and Dynlacht 2013).  
Most ciliated cells are in G0 of the cell cycle. For these cells to 
enter the mitosis stage, first the cilia need to be resorbed and 
when  mitosis is complete, the cilia will be reassembled (Quarmby 
and Parker 2005). There are 3 distinct stages in cilia assembly. 
First, a Golgi-derived vesicle containing membrane proteins 
destined to the ciliary compartment binds the distal end of the 
mother centriole and the axoneme starts to form.  This vesicle 
accumulates the essential structures inside the centriole to form 
the basal body. Next, vesicles create a sheath around the 
axoneme in which the microtubules are assembled. Finally, the 
axoneme reaches the cell surface and its membrane fuses to the 
plasma membrane to form the ciliary necklace (Pedersen, Veland 
et al. 2008).  
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 Figure 3. Diagram of ciliary structure. Photo adapted from   
Ainsworth (Ainsworth 2007). 
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1.6 Cytoskeleton 
 
The centrosome is involved in cytoskeleton regulation by its active 
participation in the assembly of microtubules, a cytoskeleton 
component that plays important roles in transport of proteins and 
organelles, cell polarity and mitotic spindles (Luders and Stearns 
2007). The cytoskeleton plays an important role in 3 cellular 
functions. First, it organizes the cell content and components. 
Second, it helps connect the cells with the external environment 
physically and biochemically. Finally, it is implicated in cellular 
movement (Fletcher and Mullins 2010).  
Three main polymers of cytoskeleton are actin filaments, 
microtubules and intermediate filaments. The polymerization and 
depolymerization of actin filaments and microtubules lead to 
changes in cell shape and with the help of motor proteins, cellular 
components are organized. The differences between the 3 
cytoskeletal subunits go back to their mechanical stiffness, 
dynamics of their assembly, their polarity and molecular motors 
associated with them (Fletcher and Mullins 2010). 
Microtubules are the stiffest subunit and have a very complicated 
assembly dynamic. Their stiffness is beneficial in the interphase 
stage of cell cycle by assembling the radial array of microtubules 
that help the intracellular traffic. During mitosis, microtubules 
form mitotic spindles which enable chromosome alignment 
through dynamic instability of microtubules (Fletcher and Mullins 
2010). 
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Although actin filaments are less rigid than microtubules by 
themselves, high concentration of the crosslinkers binding them 
make stiff isotropic, bundled and branched networks. These 
networks are involved in chemotaxis, cell-cell communication and 
phagocytosis. Unlike microtubules, actin filaments elongate 
steadily in the presence of nucleotide-bound monomers and their 
assembly is in response to the local activity of signaling systems. 
The intermediate filaments are the least stiff subunit and are not 
polarized. They interact with both microtubules and actin 
filaments through plectins and are usually assembled in  response 
of mechanical stress (Fletcher and Mullins 2010). 
MiĐrotuďules are tuďular polǇŵers Đoŵposed of α aŶd β tuďuliŶs 
that assoĐiate to forŵ protofilaŵeŶts ǁith the β-tubulin subunit 
oŶ the plus eŶd of ŵiĐrotuďules aŶd α-tubulin subunit on the 
ŵiŶus eŶd. A third ŵeŵďer of tuďuliŶ faŵilǇ, γ-tubulin is 
important for microtubule nucleation and assembly. Microtubule 
assembly needs GTP hydrolysis so the GDP-tubulin is stabilized at 
the plus end by a short cap (Luders and Stearns 2007, Wade 
ϮϬϬϵͿ. The α aŶd β ŵoŶoŵers are ϱϱ kDa aŶd ďoth ĐoŶsist of ϰϱϬ 
amino acid residues. Tubulin is subject to several post-
translational modifications like acetylation, detyronization and 
polyglutamylation. These modifications determine the stability of 
microtubules (Wade 2009).  
When tubulin concentrations are low, the microtubule nucleation 
process is kinetically limiting. Therefore, nucleation takes place in 
specific structures called microtubule organizing centers (MTOCs) 
such as centrosome (Wiese and Zheng 2006). During interphase, 
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microtuďules get ŶuĐleated iŶ MTOCs riĐh iŶ γ-TuRC whereas 
during mitosis they nucleate on centrosomes which are located at 
spindle poles and the astral microtubules are formed dynamically 
(Wade 2009). 
A large number of proteins interact with microtubules and are 
referred to as microtubule-associated proteins (MAPs). Two 
classical types of MAPs isolated from brain are the high-
molecular-weight MAPs (200-300 kDa) and the lower molecular 
weight tau proteins which is 55 kDa. The main role of these 
proteins is microtubule stabilization against dynamic instability 
(Wade 2009). The motor proteins, kinesin and dynein, are 
important microtubule partners during cell division in eukaryotes. 
Kinesins have 2 conserved regions which are responsible for ATP-
binding and microtubule-bindng. Conventional kinesins move 
toǁard plus eŶd of ŵiĐrotuďules at ϭμŵ/s iŶ ǀitro. DǇŶeiŶs also 
use ATP energy to move but they move towards the minus end of 
microtubules. Dyneins can move laterally and reverse direction as 
well. They have 1-3 heavy chains plus several intermediate and 
light chains. Their important function is in orientation of mitotic 
spindle and in nuclear migration (Wade 2009). 
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1.7 Diseases 
 
There are 2 types of centrosome abnormalities: 1. structural 
defect and 2. numerical aberrations. The structural defects are 
largely due to changes in the expression levels of different 
centrosomal proteins or altered posttranslational modifications 
that would lead to an enlarged centrosome or reduction in MT 
nucleation. Also,  a reduction of centrosome size reduces spindle 
length. Structural defects are common in tumors. As for numerical 
aberrations, overduplication of centrosome is a good example of 
these kinds of defects and is widely found in tumors. Both these 
aberrations could cause diseases (Greenan, Brangwynne et al. 
2010, Bettencourt-Dias, Hildebrandt et al. 2011). Some common 
ones are discussed below.  
 
1. Aneuploidy 
Centrosomal deregulation usually leads in chromosomal instability 
(CIN) and aneuploidy. Aneuploidy is the result of chromosome 
missegregation and is caused by abnormal mitotic spindle 
assembly. This is mostly a numerical defect (Kumar, Rajendran et 
al. 2013).  
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2. Cancer 
Important evidence of the role of centrosomal defects in 
tumorigenesis came from the fact that p53 knock down resulted 
in centrosome amplification in mouse fibroblasts and skin tumors. 
Centrosome abnormalities are  often observed in breast, prostate, 
lung, colon and brain cancers. There are several pathways leading 
to centrosome overduplication. First, the overexpression of PLK4 
or mutation in oncogenes or tumor suppressors will cause 
centriole over-duplication. Another pathway is through cell 
division failure and cell-cell fusion which causes tetraploidisation 
(Nigg 2006, Bettencourt-Dias, Hildebrandt et al. 2011). 
Centrosomal amplifications and defects usually occur very early in 
tumorigenesis and are associated with initiation of chromosomal 
changes. These defects get more severe with tumor progression. 
In a study on cervical carcinoma, centrosomal amplification 
increased 20% in epithelia of grade 1 tumors, 5o% in grade 2 
tumors and finally in grade 3 tumors, this increase was 70%. In 
tumor cell lines, centrosome overduplication is mainly caused by 
the reduced activity of p53 and the overexpression of its 
inactivating protein, Mdm2, which allows polyploid cells to 
proliferate rather than undergoing apoptosis (Saunders 2005).  
Some studies have suggested the link between DNA damage and 
centrosome numerical abberations. For instance, DNA damage 
could lead to centrosomal splitting in Drosophila and mammalian 
cells. Furthermore, the overexpression of ATM/ATR could result in 
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this amplification. The consequences could be cell cycle arrest or 
errors in mitosis (Saunders, 2005).   
 
3. Brain development 
The most common phenotypes in this category are neural 
migration disorders such as lissencephaly, disorders of brain 
growth such as microcephalic osteodysplastic primordial dwarfism 
and primary microcephalies (MCPH) in which the size of brain is 
significantly reduced. The genes affected by primary 
microcephalies are either involved in centriole duplication or 
centrosome maturation. Centrosome P4.1 associated protein 
(CPAP) and CEP152 are MCPH proteins essential in both of these 
processes. Also, MCPH mutations could lead in a reduction of the 
whole body including the size of the brain (Bettencourt-Dias, 
Hildebrandt et al. 2011). 
 
 
4. Ciliopathies 
Defects in motile cilia cause pathologies referred to as primary 
cilia dyskinesia (PCD). Patients with PCD show body asymmetry 
which is an indication of the importance of ciliary motility in 
directional flow in early embryos and initiation of normal left-right 
developmental program. Mutations sometimes happen in the 
primary cilia and cause defects in its structure or function which 
would lead in diseases such as polycystic kidney disease (PKD), 
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nephronophthisis, retinitis pigmentosa, Bardet-Biedle (BBS) and 
Joubert and Meckel syndrome. Although cilia structure might not 
be altered in these disorders, its sensory function might have 
defects and therefore affects multiple organs such as kidney, 
retina, brain, bones and liver (Bettencourt-Dias, Hildebrandt et al. 
2011). 
 
 
6. Defects in intracellular transport 
Because of its microtubule organizing ability, centrosome plays a 
crucial role in intracellular transport and spatial organization of 
cellular organelles. Huntington disease is one of the 
neurodegenerative disorders that is a consequence of defects in 
microtubule-dependent vesicular transport. This disease is 
characterized by loss of cognitive function and motor defects. 
Huntington-associated protein (HAP1) binds to dynactin and 
pericentriolar material 1 protein (PCM1) which is involved in 
centrosome and basal body function. Studies in fibroblast cultures 
of patients with Huntington disease exhibit aberrant centrosome 
numbers, a reduction in mitotic index, an increase in aneuploidy 
and finally persistence of midbody (Badano, Teslovich et al. 2005). 
Since centrosome deregulation is the cause of several diseases, it 
is important to study novel centrosomal proteins and their 
functions as potential therapeutic targets. 
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1.8 CEP78 
 
CEP78 is a novel centrosomal protein first identified in 2003 
through proteomic characterization of human centrosome. In this 
study, a mass-spectrometry analysis of human centrosomes in 
interphase was performed and 23 new components were 
discovered. CEP78 was one of them (Andersen, Wilkinson et al. 
2003). The CEP78 gene is located on chromosome 9q21. Human 
CEP78 protein has several isoforms, the biggest one a 78 kDa 
protein consisting of 722 amino acids. This protein has orthologs 
in mouse, chicken, lizard, tropical clawed frog, zebrafish and fruit 
fly. As for the structure of this protein, it consists of 4-6 Leucin-
rich Repeats (LRRs) and one coiled-coil domain. Very few papers 
have discussed possible CEP78 functions. In one such studies, the 
possible role of CEP78 in centriole anchoring and ciliogenesis was 
discussed (Azimzadeh, Wong et al. 2012). Also, in a study carried 
out on the effect of standard treatments on immune responses in 
prostate cancer patients, CEP78 was one of the proteins 
recognized for its treatment associated autoantigen reactivity 
(Nesslinger, Sahota et al. 2007). In a study carried out in 2012, 
CEP78 expression upregulated 5 fold by noise stress in rat 
cochleae (Han, Hong et al. 2012). Another study on the genes 
altered by ethanol treatment during neurodevelopment showed 
that CEP78 expression decreased on E 14/16 and P 4/7 (Kleiber, 
Mantha et al. 2013). Finally, a study in 2013 claimed the 
interaction between CEP78 and PLK4, CP110 and CEP97 (Baffet, 
Martin et al. 2013). Since all these three proteins are involved in 
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centriole duplication, it is necessary to look at the possible role of 
CEP78 in this process. The objective of my project was to further 
study CEP78 localization, function and interactions.  
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Chapter 2 Materials and Methods 
 
2.1 Materials 
 
2.1.1   Chemicals 
β-glǇĐerophosphate, β-mercaptoethanol, AEBSF, Ampicillin, 
Aprotinin, CaCl2, DAPI, DMP, DTT, EDTA, Ethanolamine, 
Glutathione, Glycerol, Glycine, HCl, Hepes, IPTG, KCl, Leupeptin, 
Methanol, MgCl2, Tris, Na Borate, NaCl, Nocodazole, NP-40, 
Paraformaldehyde, PBS, SDS, Triton 
 
2.1.2   Solutions, Buffers and media 
2.1.2.1  Coomassie 
(50% Methanol; 10% Acetic Acid; 0.2% Coomassie Blue; dH2O) 
 
2.1.2.2 ELB+ Buffer 
(1M Hepes pH 7; 5M NaCl; 0.5M EDTA pH 8; 10% NP-40; 1mM 
DTT; Ϭ.ϱŵM AEB“F; LeupeptiŶ Ϯμg/ŵl; AprotiŶiŶ Ϯμg/ŵl; ϭϬŵM 
NaF; ϱϬŵM β-glycerophosphate; dH2O) 
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2.1.2.3   Glutathione elution buffer 
(100mM Tris pH 7.9; 120mM NaCl; 20mM Glutathione; 1mM DTT; 
0.2mM AEBSF, dH2O) 
 
2.1.2.4   4X Lower Gel Buffer 
(1.5mM Tris-HCl pH 8.8; 0.4% SDS; dH2O) 
 
2.1.2.5  0.1 HEMGN 
(100mM KCl; 25mM Hepes pH 7.6; 0.2mM EDTA pH 8; 12.5mM 
MgCl2; 10% Glycerol; 0.1% NP-40; 1mM DTT; 0.2mM AEBSF; 
Leupeptin 2 μg/ml ; Aprotinin 2 μg/ml, dH2O) 
 
2.1.2.6 Maniatis 5x SDS Page Running Buffer 
(25mM Tris; 250mM glycine; 0.1% SDS; dH2O) 
 
2.1.2.7   Stripping buffer 
;ϮϬ% “D“, ϭϰ.ϰM  β-mercaptoethanol; 1M Tris; dH2O) 
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2.1.2.8 4X Upper Gel Buffer 
(0.5M Tris-HCl pH 6.8; 0.4% SDS; dH2O) 
 
2.1.2.9   Western Transfer Buffer 
(50mM Tris; 380mM Glycine; 0.1% SDS; 20% Methanol; dH2O) 
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2.2      Methods 
 
2.2.1    Bacterial methods 
 
2.2.1.1   Purification of GST- tagged CEP78 and GST proteins 
 
The bacteria E.coli DHϱα straiŶ ĐoŶtaiŶiŶg truŶĐated C ;aŵiŶo 
acids 590-722) and N (amino acids 1-146) terminal CEP78 
plasmids were inoculated from glycerol stock in Luria broth (LB) 
ŵedia ĐoŶtaiŶiŶg ϭϬϬ μg/ŵl AŵpiĐilliŶ aŶd greǁ oǀerŶight. The 
protein expression was induced by adding 1M IPTG to the cultures 
and incubating them at 20°C for 16 hours. Next, the bacteria were 
pelleted at 4000 rpm. After the pellets were washed with 1X PBS 
(Phosphate Buffered Saline), they were resuspended in 0.1 
HEMGN buffer. Then, the bacterial suspensions were sonicated 3 
times with 15 second bursts at the microtip limit. The lysates were 
centrifuged at 10000 rpm(Revolutions Per Minute) and the 
supernatants were transferred to Eppendorf tubes. Next, the 50% 
slurry Glutathione agarose beads were prepared. To do this, the 
beads were first resuspended in 0.1 HEMGN buffer and rocked for 
1 hour at room temperature. Next, they were equilibrated in 0.1 
HEMGN buffer and finally resuspended in 0.1 HEMGN buffer to 
make 50% slurry. The beads then were added to the extracts and 
the samples got incubated at 4°C for 1 hour. After the incubation, 
the samples were spun at 3000 rpm and the supernatants were 
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aspirated. The beads were washed with 0.1M HEMGN and then 
eluted with 1ml glutathione elution buffer for 20 minutes and 
spinned at 3000 rpm. Finally, the eluates were dialyzed against 
0.1M HEMGN at 4°C overnight. The dialyzed proteins were stored 
at -80°C or run on a 10% SDS-PAGE gel and coomassie stained.  
 
 
2.2.1.2    CEP78 Antibody purification  
 
2.2.1.2.1 Making Columns 
 
At first, the concentration of dialyzed GST and GST-CEP78 proteins 
was measured by running them on SDS-PAGE, doing a Coomassie 
staining and comparing the intensity of their bands to the ones of 
different BSA concentrations. Next, the GST-agarose beads were 
added to the proteins and incubated at 4°C for 2 hours. After the 
binding, the samples were spinned down at 1000 rpm and washed 
with 1X PBS. Next, the beads were washed and resuspended in 
0.2M Na Borate pH=9. For crosslinking, solid DMP(Dimethyl 
pimelimidate)  was added to beads and they were incubated at 
room temperature for 30 minutes. Next, the samples were spun 
at 1000 rpm and the beads were washed, resuspended in 0.2M 
Ethanolamine pH=8 and incubated at room temperature. After 2 
hours, the samples were spun at 1000 rpm and the beads were 
washed with 1X PBS and  0.1 Glycine pH=2.5. Following another 
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round of washing with 1X PBS, the beads were transferred to the 
columns. 
 
2.2.1.2.2 Purifying antibodies 
 
First, rabbits were immunized against CEP78 truncated proteins  
and their serums were collected by Cocalico Biologicals company. 
Then the serums were loaded on the GST column and incubated 
at room temperature.  After an hour, the flowthrough was 
collected from the GST column and added to the GST-CEP78 
column and incubated in room temperature. One hour later, the 
beads were washed with 1X PBS and the antibody elution was 
carried out with fractions of 0.1M Glycine pH=2.5. The eluates 
were then collected in the Eppendorf tubes already containing 1M 
Tris HCl pH=8. 
 
 
2.2.1.3 Transformation of competent cells 
 
First, the bacteria E.coli DHϱα straiŶ ĐoŵpeteŶt Đells ǁere 
thawed. Next, 10 ng DNA was added to the competent cells and 
they were incubated on ice.  Then, the samples were heat 
shocked first at 42°C for 45 seconds and then back on ice for 5 
minutes. Later, LB media was added to the cells and the samples 
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were incubated at 37°C. After an hour, the cells were spinned 
down at 9000 rpm and the supernatant was aspirated. Finally, the 
pellet was resuspended in LB media and plated on LB plates 
containing appropriate antibiotic which were incubated at 37°C 
overnight. 
 
2.2.2     Cellular methods 
 
2.2.2.1  Immunofluorescence  Assay 
 
First, the cells were washed with 1X PBS. Next, they were fixed 
with 100% iced Methanol or 4% Paraformaldehyde and washed 
with 1X PBS. Following permeabilization with PBS-1% Triton, cells 
were washed with 1% PBS and blocked with PBS-3% BSA-0.1% 
Triton. Then they were incubated with the primary antibody. After 
one hour incubation, the cells were washed with PBS-0.1% Triton. 
Next, they were incubated in dark with the secondary antibody- 
fluorochrome-labeled. One hour later, the cells were washed with 
PBS-0.1% Triton and incubated with DAPI in dark for 7 minutes. 
Then, they were washed with 1X PBS and H2O.  Once dry, the 
coverslips were mounted on slides using mounting media.  Finally, 
they were sealed with nail polish. 
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2.2.2.2 Western Blotting 
 
First, the cells were harvested by spinning at 1000 rpm for conical 
tubes or at 3000 rpm for microcentrifuge tubes. The supernatant 
was aspirated and the pellet was washed with 1X PBS. Next, the 
sample was lysed with ELB+ buffer and its protein concentration 
was measured via Biorad protein assay and Spectrophotometry. 
Then, the sample and loading dye were loaded on 10% gel  and 
run at 150V. Once the running step was complete, the transfer to 
Nitrocellulose membrane was carried out at 60V for one hour. 
Next, the membrane was blocked in 3% milk and incubated with 
the primary antibody. After 1 hour incubation at room 
temperature, the membrane was washed with H2O and incubated 
with the secondary antibody at room temperature. One hour 
later, the membrane was washed with H2O. Finally, ECL was 
added on the membrane and developing was carried out. 
 
 
 
2.2.2.3 Knock Down with siRNA 
 
First, the cells were plated in 6 well plates so that at the time of 
transfection, they were 40%-50% confluent. For transfection, the 
siIMPORTER reagent from Millipore company was diluted with 
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serum-free medium in one microcentrifuge tube and in another 
tube siRNA oligo, siRNA diluent and serum-free medium were 
mixed so that the final concentration of the oligo was 100 nM. 
Next, the content of both tubes were mixed and incubated at 
room temperature for 5 minutes. Finally, the mixture was added 
to the cells and the cells were incubated at 37°C. 
 
2.2.2.4 Plasmid Transfection with Transit reagent 
 
First, the cells were plated in 6 well plates so that at the time of 
transfection, they were 60%-70% confluent. For transfection, the 
Transit reagent was first diluted with serum-free medium and 
Ŷeǆt Ϯμg plasŵid ǁas added to it. The ŵiǆture ǁas theŶ 
incubated at room temperature for 20 minute. Finally, the 
mixture was added to the cells and the cells were incubated at 
37°C. 
 
 
2.2.2.5 Plasmid transfection with CaCl2 
 
First, the cells were plated so that at the time of transfection, they 
were 60%-70% confluent. For transfection, ϮϬμg DNA, Ϯ.ϱM 
CaCl2, 1ml 2X HEPES and H2O were mixed and incubated at room 
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temperature for 20 minutes. Finally, the mixture was added to the 
cells and the cells were incubated at 37°C. 
 
2.2.2.6 Immunoprecipitation  
 
First, the cells were lysed in ELB+ buffer for 30 minutes. Next, the 
lysate was spinned down at 14000 rpm and the supernatant was 
traŶsferred iŶto Ŷeǁ EppeŶdorf tuďes. TheŶ, Ϯμg aŶtiďodǇ ǁas 
added to the supernatant and the sample was incubated at 4°C 
for 1 hour. Following the incubation, 50% slurry protein A/G 
beads were added to the sample and once again the beads were 
incubated at 4°C for one hour. Next, the sample was spinned 
down at 3000 rpm in the cold and washed 3 times with ELB+ 
buffer. Finally, loading dye was added to the sample for western 
blotting. 
 
 
2.2.2.7 Centrosomal localization study 
 
First, the Đells ǁere treated ǁith ϭϬμM NoĐodazole aŶd iŶĐuďated 
at ϯϳ°C. After aŶ hour, the Đells ǁere fiǆed aŶd staiŶed ǁith α-
tubulin. 
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2.2.2.8 Microtubule Assay 
 
First, the Đells ǁere treated ǁith ϭϬμM NoĐodazole aŶd iŶĐuďated 
at 4°C. After an hour,  Nocodazole was aspirated from plates, the 
media was replaced and the cells were incubated at 37°C for 2, 5 
and 20 minutes. FiŶallǇ, the Đells ǁere fiǆed aŶd staiŶed ǁith α-
tubulin antibody. 
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Chapter 3 Results 
 
CEP 78 is a novel protein first identified through a mass-
spectrometry analysis of human centrosome(Andersen, Wilkinson 
et al. 2003). It consists of 722 amino acids and structurally has 4-6 
Leucine-rich repeats and a coiled coil domain. The objective of 
this project was to study the localization and function of this 
protein. For the localization study, experiments were planned to 
look at the cell cycle pattern of this protein and its centrosomal 
localization. As for the functions of CEP78, its possible role in 
different stages of centrosome cycle and its effect on some other 
centrosomal proteins were studied. 
 
 
 
3.1 CEP78 is an intrinsic component of Centrosome. 
 
It had already been shown that CEP78 is a centrosomal protein. In 
order to study whether CEP78 is a permanent component of 
centrosome or it requires microtubules for its centrosomal 
localization, retinal pigment epithelial (hTERT-RPE or RPE) cells 
were treated with nocodazole which is a microtubule 
depolymerizing agent. RPE cells were used because they are 
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normal diploid, have normal centrosome number and 
morphology, and undergo normal cell division. These traits makes 
them good candidates for studying the effect of a new 
ĐeŶtrosoŵal proteiŶ oŶ other ĐeŶtrosoŵal ĐoŵpoŶeŶts. γ-tubulin  
aŶd α-tubulin were used as control proteins. In fact, what we 
expected was that the net pattern of alpha-tubulin disappeared 
due to microtubule depolymerization whereas the genuine 
centrosomal proteins would remain. Following an 
iŵŵuŶofluoresĐeŶĐe assaǇ aŶd staiŶiŶg the Đells ǁith α-tubulin, 
γ-tubulin (a permanent centrosomal protein) and CEP78 
aŶtiďodies, it ǁas oďserǀed that the Ŷet patterŶ of α-tubulin 
disappeared ǁhereas γ-tubulin and CEP78 proteins remained at 
the centrosome. These results indicated that CEP78 is indeed a 
stable centrosomal component and does not require microtubules 
for its centrosomal localization [Figure 4]. 
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Figure 4: CEP78 is an intrinsic component of centrosomes and does not require microtubule for 
its centrosomal localization. RPE cells are treated with nocodazole for 1 hour, fixed and stained 
ǁith α-tuďuliŶ,γ-tubulin and CEP78.  
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3.2 CEP78 is a centriolar protein present at the distal end. 
 
To see whether CEP78 is present at the distal or proximal end of 
centrioles, co-localization of this protein with other centrosomal 
proteins was studied in RPE cells by immunofluorescence assay 
and fluorescence microscopy. Several proximal (C-Nap1, 
Polyglutamylated Tubulin) and distal (CEP170, POC5) proteins 
were studied at this step. The results indicated that CEP78 did not 
colocalize with the proximal proteins C-Nap1 and 
Polyglutamylated Tubulin. However, the distal proteins CEP170, 
Centrin and POC5 showed a close co-localization with CEP78. In 
conclusion, CEP78 localizes to distal end of centrioles [Figure 5]. 
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Figure 5: CEP78 localizes to the distal end of centrioles. RPE cells are fixed and stained with 
CEP170, Polyglutamylated tubulin, C-Nap1, POC5 and CEP78.  
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3.3 CEP78 localizes to mature centrioles.  
 
In order to study the cell cycle pattern of CEP78, co-localization 
with centrin (centriolar marker on mother, daughter and 
procentrioles), was carried out in RPE cells at different stages of 
cell cycle by immunofluorescence assay and fluorescence 
microscopy. Different stages of the cell cycle were identified 
based on centrin and DAPI staining in asynchonzied cells and 
Polyglutamylated tubulin for G0 cells. Centrin is a centriolar 
marker which appears as 2 dots during G1 (mother and daughter 
centrioles) and 4 dots during S, G2 and mitosis (mother, daughter 
and procentrioles). During the G0, G1, S and early G2 phases of 
interphase, there were 2 CEP78 dots in the cells with the intensity 
of one dot stronger than the other one. My previous 
colocalization study with CEP170 (a sub-distal appendage protein 
on mother centriole) had indicated that the stronger dot belongs 
to the mother centriole. Measuring the intensity of these dots 
using the software Velocity showed that the mother centriole dot 
was 1.9 times stronger than the daughter centriole dot. In order 
to calculate the above number, first a  number of images were 
taken by the microscope camera and each image was analyzed 
separately by the Velocity software to measure the intensity of 
the CEP78 dots on mother and daughter centrioles. Finally, an 
average was taken of the intensity differences. During late G2 
phase of interphase, the intensity of the mother and daughter 
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centrioles became quite equal implicating that daughter has 
matured into a mother. Also, 2 new weak CEP78 dots started to 
appear on the procentrioles evolving to the daughter centrioles. 
As the cells went through mitosis, the intensity of the new dots 
increased gradually. In prophase the CEP78 dots have a quite 
diffused staining but by the end of telophase, 2 obvious CEP78 
dots could be observed in each daughter cell. The co-localization 
study with Centrin indicated that CEP78 dots only localized to the 
mother and daughter centrioles but not procentrioles and that 
CEP78 is stronger on the mother compared to the daughter 
centriole[Figure 6]. 
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Figure 6: CEP78 localization pattern at different stages of cell cycle. RPE cells are fixed 
and stained with Centrin and CEP78.  
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3.4 Leucin rich repeats are responsible for centrosomal 
localization of CEP78. 
 
The CEP78 protein consists of 4-6 Leucin rich repeats (LRRs), 
amino acids 147-308, and one coiled coil domain, amino acids 
450-497. To address the importance of these domains, several 
CEP78 fragments with deletion in one or some of these domains 
were expressed in RPE cells and their expression pattern was 
studied by immunofluorescence assay and fluorescence 
microscopy. The results showed three distinct phenotypes: 
centrosomal localization, microtubule binding and aggregate 
formation [Table 1]. All these three patterns were observed after 
overexpression of full length CEP78 as well. While the fragments 
with deletion in any LRRs could not localize to ceŶtrosoŵe ;Δϭϰϳ-
ϭϳϰ, ΔϮϮϲ-Ϯϱϰ, ΔϮϱϱ-ϮϴϮ aŶd ΔϮϴϯ-308), the fragments that 
ĐoŶtaiŶed all the LRRs loĐalized to ĐeŶtrosoŵe ĐlearlǇ ;ΔϰϱϬ-497, 
1-445). About 70% of the cells expressing full length CEP78 (1-
722) also showed centrosomal localization [Figure 7]. 
Furthermore, some of the fragments including the fragment 221-
445 as well as 40% of the cells expressing full length CEP78 
showed microtubule binding pattern. In fact, 70% of the cells 
expressing fragment 221-445, showed the net pattern of 
microtubules. This fragment contains the three middle LRRs. 
Although the microtubule binding pattern is observed, further 
studies are required to confirm this binding. Finally, the 
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expression of some of the fragments including 1-220 resulted in 
aggregate formation. This pattern was only observed in 15% of 
the cells expressing the full length CEP78 [Figure 8].The protein 
aggregates could be indicative of a malfunction of the normal 
process of protein turnover or a problem in the recruitment of the 
protein to centrosome. These results show that LRRs are crucial 
for centrosomal localization and probably MT binding of CEP78. 
They can function by interacting with other proteins that help 
recruit CEP78 to centrosome or microtubules.  
 
 
 
 
 
 
 
 
 
 
 
 
  64 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 1: Percentage of RPE cells transfected with CEP78 fragments showing 
centrosomal localization or microtubule binding pattern 
 
 
Construct Centrosomal 
localization 
Microtubule binding 
Full Length Cep78 74% 42% 
Δ ;ϰϳ-174) 2% 0% 
Δ ;ϮϮϲ-254) 0% 0% 
Δ ;Ϯϱϱ-282) 0% 0% 
Δ ;Ϯϴϯ-308) 0% 0% 
Δ ;ϰϱϬ-497) 83% 10% 
1-220 0% 0% 
221-722 0% 33% 
1-445 42% 32% 
221-445 7% 70% 
446-722 0% 0% 
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Figure 7: LRRs are necessary for centrosomal localization. RPE cells are  transfected with 
flag tagged CEP78 fragments, fixed and stained with flag and Centrin.   
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Figure 8: Some fragments show a) microtubule binding b) aggregate formation. RPE cells 
are transfected with flag tagged CEP78 fragments, fixed and stained with flag and 
Centrin.  
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3.5 CEP78 overexpression does not result in centriole duplication 
or accumulation. 
 
Since CEP78 is a centriolar protein, I speculated that modulation 
of its protein levels could affect the number of centrioles within a 
cell. In order to study the possible role of CEP78 in centriole 
duplication or accumulation, the full length protein was expressed 
in RPE cells and its effect on CEP164 (mother centriole marker), 
SAS-6 (procentriole marker) and centrin (marker of mother, 
daughter and procentrioles) was studied. Since most cells were in 
G1 phase and only had one mother centriole, most control cells 
had only one CEP164 dot. Similar to control, most transfected 
cells had 1 CEP164 dot and there was no increase/decrease in the 
number of mother centrioles. Studying SAS-6 showed no 
significant difference between the control and transfected cells 
either and most cells had zero (no procentriole in G1 phase) or 2 
(2 procentrioles from G2) SAS-6 dots based on the stage of cell 
cycle. This meant that there was no change in the number of 
procentrioles. Also, looking at centrin confirmed the results of 
CEP164 and SAS-6 since the number of centrioles did not change. 
So these experiments indicate that CEP78 overexpression does 
not result in centriole duplication or accumulation [Figure 9]. 
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Figure 9: CEP78 overexpression does not cause centriole overduplication or 
accumulation. RPE cells are transfected with flag tagged full length CEP78 and CAIP 
(control), fixed and stained with flag, CEP164, SAS6 and Centrin. 
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3.6 CEP78 overexpression does not affect or bind POC5 and 
PLK1, proteins involved in centriole maturation. 
 
As mentioned before, two new endogenous CEP78 dots start to 
appear at late G2 and also the intensity of mother and daughter 
dots becomes equal at this point. Since this phase coincides with 
centriole maturation in centrosome cycle, there is the possibility 
that CEP78 is involved in this process. For this purpose, the full 
length CEP78 was expressed in RPE cells and its effect on POC5 
was studied by immunofluorescence assay and fluorescence 
microscopy. POC5 is a protein involved in centriole elongation and 
has a cell cycle pattern similar to CEP78, that is there are 2 POC5 
dots during G1 and S phase and late G2, 2 new weak POC5 dots 
start to appear that become strong gradually. The results 
indicated that similar to the control, the transfected cells had 
mostly 2 dots and there was no significant difference in the 
number of POC5 dots [Figure 10a]. Also since POC5 is a distal 
centriolar protein, its interaction with CEP78 was studied by 
expressing full length flag-CEP78 and flag (control) in 293 cells and 
doing a flag immunoprecipitation to pull down CEP78 protein and 
its interacting proteins.This was followed by Western blotting of 
POC5. There was no interaction between the 2 proteins [Figure 
10b]. The interaction between CEP78 and PLK1, another protein 
involved in centriole maturation, was studied with the same 
method discussed for POC5 as well. No interaction was observed 
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between CEP78 and PLK1 either [Figure 10b]. Therefore, CEP78 
does not interact with POC5 or PLK1, proteins involved in 
centriole maturation and its overexpression does not have an 
effect on the number of POC5 dots. It would be interesting in the 
future to study the effect of overexpressing POC5 on the number 
of CEP78 dots and also the effect of CEP78 overexpression on 
centriole elongation. 
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Figure 10: a) CEP78 overexpression does not affect POC5 dots. RPE cells are transfected 
with flag tagged full length CEP78 and CAIP (control), fixed and stained with flag and 
POC5.  b) CEP78 does not interact with POC5 or PLK1. 293 cells are transfected with flag 
tagged full length CEP78 and Flag (control), immunoprecipitated for flag and western 
blot was carried out for POC5. IN represents input and IP represents 
immunoprecipitation. 
POC5 dots
0
10
20
30
40
50
60
70
80
90
100
2 dot >2 dots
POC5 dots
%
 
Ce
lls Control
Cep78
 
 
     
 
 
Fl-Cep78  Flag  Fl-Cep78  Flag 
Flag 
Poc5 (63 KD) 
 
 
       IP                          In                
PLK1  (66KD) 
Flag 
In IP 
b 
a 
Fl-Cep78  Flag  Fl-Cep78  Flag 
  72 
3.7 CEP78 overexpression does not have a significant effect on 
other centrosomal proteins. 
 
In order to study the effect of CEP78 overexpression on other 
centrosomal proteins and the PCM integrity, the full length 
protein was expressed in RPE cells and the cells were stained for 
differeŶt ĐeŶtrosoŵal ŵarkers iŶĐludiŶg γ-tubulin and Pericentrin 
by immunofluorescence assay.  No significant difference was 
observed in the number of any of the above centrosomal 
proteins. These results indicate that CEP78 overexpression does 
no affect PCM integrity and other centrosomal components 
[Figure 11]. 
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Figure 11: CEP78 overexpression does not affect Gamma-tubulin and Pericentrin dots. 
RPE cells are transfected with flag tagged full length CEP78 and CAIP (control), fixed and 
stained with flag and Gamma-tubulin amd Pericentrin. 
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3.8 CEP78 overexpression reduces the number and intensity of 
CEP170, a sub-distal appendage protein. 
 
The only protein that showed a difference after CEP78 
overexpression was CEP170 which is a sub-distal appendage 
marker. Following the overexpression of the full length CEP78 in 
RPE cells, an immunofluorescence assay was carried out and the 
cells were stained for CEP170. Comparing  control and transfected 
cells showed that the number of the transfected cells not having 
CEP170 dots increased. In fact 22% of the transfected cells did not 
have CEP170 dot compared to 4% in control [Figure 12a]. Also, the 
intensity of CEP170 dots decreased significantly in the transfected 
cells. Measuring the intensity of CEP170 dots by fluorescence 
microscopy and the software Velocity, indicated a decrease of 
about 3.7 times in the transfected cells. A similar procedure had 
already been used to compare the intensity of CEP78 dots on 
mother and daughter centrioles. Next, the expression level of 
CEP170 was checked in transfected cells. For this purpose, the full 
length CEP78 was expressed in 293 cells and a western blot was 
carried out. The comparison between the control sample 
expressing Flag and CEP78 overexpressing samples did not show a 
decrease in the expression level of CEP170 [Figure 12b]. Finally, 
the interaction between CEP78 and CEP170 was studied by 
expressing the full length CEP78 in 293 cells, doing flag 
immunoprecipitation and western blotting for CEP170. No 
  75 
interaction between the 2 proteins was observed [Figure 10b]. 
Overexpressing GFP-CEP170 in 293 cells, immunoprecipitation 
and western blotting for CEP78 did not show an interaction either 
[Figure 12c]. Since CEP170 is a sub-distal appendage protein, it 
was necessary to check the effect of CEP78 overexpression on 
other sub-distal appendage proteins. One of these proteins is 
Ninein. Once again, the full length CEP78 was expressed in RPE 
cells and an immunofluorescence assay was carried out to stain 
them for Ninein. The results indicated that unlike CEP170, the 
number of Ninein dots did not decrease and their intensity did not 
change either [Figure 13A]. Also the possible interaction between 
CEP78 and Ninein was studied by the same method used for 
CEP170. No interaction was observed between the two proteins 
[Figure 13b]. So the results indicate that CEP78 overexpression 
decreases both the number and intensity of CEP170 dots but does 
not decrease its expression level. This implies that CEP78 does not 
regulate the expression level of CEP170 but it might affect the 
recruitment of CEP170 to centrosome. This result was not 
confirmed for Ninein, another sub-distal appendage protein. Also, 
there was no interaction between CEP78 and CEP170 or Ninein. 
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Figure 12: CEP78 overexpression a) decreases the number of CEP170 dots. RPE cells are 
transfected with flag tagged full length CEP78 and CAIP (control), fixed and stained with 
flag and CEP170. b) does not decrease CEP170 expression level. RPE cells are transfected 
with flag tagged full length CEP78 and flag (control) and western blots were carried out 
for CEP170. c) CEP170 does not interact with CEP78. 293 cells are transfected with GFP- 
tagged CEP170 and GFP (control), immunoprecipitated for GFP and western blots were 
carried out for CEP78. IN represents input and IP represents immunoprecipitation. 
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Figure 13: a) CEP78 overexpression does not decrease the number of ninein dots. RPE 
cells are transfected with flag tagged full length CEP78 and CAIP (control), fixed and 
stained with flag and Ninein. b) CEP78 does not interact with CEP170, Ninein and α- 
tubulin.293 cells are transfected with  flag- tagged CEP78 and flag (control), 
immunoprecipitated for flag  and  western blots were carried out for CEP170, Ninein and 
α-tubulin. IN represents input and IP represents immunoprecipitation.  
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3.9 CEP78 overexpression stabilizes microtubules after 
nocodazole treatment. 
  
Since RPE cells overexpressing full length CEP78 and some CEP78 
fragments showed microtubule binding pattern, a microtubule 
assay was carried out to see the effect of nocodazole on 
transfected cells. For this assay, cells were treated with 
nocodazole and after the removal of the nocodazole from the 
wells and replacing the media, they were incubated at 37°C for 2, 
5 and 20 minutes. The purpose of this experiment was to study 
the effect of CEP78 overexpression on microtubule stability and 
repolymerization following nocodazole treatment. The cells that 
were not transfected and also the cells transfected for full length 
NPHP5 were used as a control for this experiment. The reason 
NPHP5 was used as control is that its overexpression does not 
have any effect on microtubule stability. Finally, the cells were 
staiŶed for α-tubulin by immunofluorescence assay and studied 
by fluorescent microscopy. Before the treatment, both the 
ĐoŶtrols aŶd CEPϳϴ oǀereǆpressiŶg Đells had a Ŷet α-tubulin 
pattern due to intact microtubules. The results showed that 
following nocodazole removal, the controls had depolymerized 
microtubules and their net pattern was not observed anymore 
whereas 86% of the cells overexpressing full length CEP78, still 
had their microtubules. This could be because CEP78 binds to 
microtubules and prevents their depolymerization. After 2 and 5 
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minute incubation at 37°C, some filaments started to appear in all 
samples but these filaments were significantly more in CEP78 
overexpressing cells. Finally, after 20 minutes, asters started to 
form in controls whereas in cells overexpressing full length CEP78, 
these asters were not as clear. This could be because the majority 
of microtubules did not depolymerize after the treatment [Figure 
14]. In order to study the possible interaction between CEP78 and 
alpha-tublin, full length CEP78 was expressed in 293 cells, a flag 
immunoprecipitation was carried out and the membrane was 
stained for alpha-tubulin. No interaction was observed (Figure 
13b). Next, to make sure the observed pattern is not exclusive to 
RPE cells, nocodazole treatment was also carried out on ARPE 
cells expressing full length CEP78. ARPE cells are derived from RPE 
cells and contain a spontaneous mutation. The results indicated 
that the microtubule binding pattern was observed in 74% of the 
transfected ARPE cells as well. Next, CEP78 fragments were 
studied after nocodazole treatment. The fragments that already 
showed microtubule binding pattern (1-445, 221-445, 221-722, 
ΔϰϱϬ-497), were able to stabilize microtubules after nocodazole 
treatment as well [Figure 15]. This could help identify the region 
of CEP78 protein involved in microtubule binding and 
stabilization. 
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Figure 14: CEP78 overexpression stabilizes microtubules after nocodazole treatment in RPE cells. 
RPE cells are transfected with full length CEP78 and full length NPHP5 (control), treated with 
nocodazole for 1 hour, incubated back at 37°C for 0, 2 and 20 minutes, fixed and stained with α-
tubulin and flag.   
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Figure 15: a) Some CEP78 fragments stabilize microtubules after nocodazole treatment in RPE 
cells. RPE cells are transfected with CEP78 fragments (221-445, 221-722, 1-ϰϰϱ aŶd Δ ;ϰϱϬ-497)), 
treated with nocodazole for 1 hour, fiǆed aŶd staiŶed ǁith α-tubulin and flag b) ARPE cells 
overexpressing CEP78 also keep their microtubules after nocodazole treatment. ARPE cells are 
traŶsfeĐted ǁith full leŶgth CEPϳϴ, treated ǁith ŶoĐodazole for ϭ hour, fiǆed aŶd staiŶed ǁith α-
tubulin and flag  
a 
b 
α- tubulin 
Flag 
α- tubulin 
Flag 
  83 
Chapter 4 Discussion 
 
The cell cycle is an important cellular process modulated and 
regulated by different molecules, pathways and organelles and its 
misregulation could result in several diseases. One cellular 
organelle crucial in the cell cycle regulation is the centrosome 
which consists of two centrioles embedded in an amorphous 
proteinacious material called pericentriolar material (PCM). 
Around 500 centrosomal proteins have been identified so far and 
any abberations in these proteins can cause defect in the number 
or structure of centrosome and lead to several diseases including 
cancer, ciliopathies and brain disorder syndromes. Therefore, it is 
vital to study the function of novel centrosomal proteins for 
potential therapeutic applications. 
 
The objective of this research was to study the localization and 
function of CEP78 as a novel centrosomal protein. CEP78 was first 
identified by Anderson et al. in 2003 (Andersen, Wilkinson et al. 
2003). They isolated centrosome from the cells in the interphase 
and did a mass-spectrometry analysis to identify any new 
centrosomal proteins. Following this analysis, they studied the 
discovered proteins by correlation with already known 
centrosomal proteins and also their in vivo localization. They 
identified 23 new centrosomal components including CEP78. This 
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78kDa protein has several isoforms with the longest one 
consisting of 722 amino acids. It also has orthologs in mouse, 
chicken, lizard, tropical clawed frog, zebrafish and fruit fly.  The 
human cep78 gene is located on chromosome 9. 
 
As it was mentioned in the previous paragraph, CEP78 had already 
been discovered as a centrosomal protein but further studies 
were necessary to confirm whether it is a permanent component 
of centrosomes and also where in centrosome it localizes. 
Depolymerization of RPE microtubules by nocodazole indicated 
that CEP78 is a stable centrosomal protein that does not require 
microtubules for its centrosomal localization. Also, colocalization 
studies between CEP78 and other centrosomal proteins showed 
that this protein does not colocalize with the proximal centriolar 
proteins such as C-Nap1 or Polyglutamylated tubulin.  On the 
other hand, the proteins localizing to the distal end of centrioles 
such as CEP170, Centrin and POC5 showed a close colocalization 
with CEP78. These results suggest that CEP78 is a permanent 
component of the distal end of centrioles. For further studies, 
electron microscopy can be carried out to determine whether 
CEP78 is a distal or sub-distal protein. 
 
Centrosomal proteins show different patterns during the cell cycle 
based on their functions and studying this pattern could provide 
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us with more information regarding the function of a new protein. 
Thus CEP78 was studied during different stages of the cell cycle by 
colocalization with the centriolar marker, Centrin, and using DAPI 
to identify the nuclei cycle. The results indicated that there are 
two CEP78 dots on the mother and daughter centrioles in G1, S 
and early G2 phases of interphase, with the intensity of the one 
on the mother 1.9 times stronger than the one on the daughter. 
Late G2, the intensity of the two existing dots becomes equal and 
two new weak CEP78 start to appear. The new dots get stronger 
as the cell goes through mitosis and by the end of the telophase 
each daughter cell has two CEP78 dots. The colocalization studies 
with Centrin showed that CEP78 only localizes to the mature 
centrioles, mother and daughter, and not the procentrioles. Since 
late G2 coincides with centriole maturation phase of centrosome 
cycle during which the daughter centriole acquires appendages to 
become mother and also procentrioles elongate, the increase in 
the intensity of the daughter centriole and appearance of the two 
new CEP78 dots suggest the possible role of CEP78 in centriole 
maturation process. To further study this hypothesis, more 
experiments were planned and carried out. First, the effect of the 
overexpression of CEP78 on another protein involved in centriole 
maturation, POC5, was studied. Next, the possible interaction 
between CEP78 and the two proteins POC5 and PLK1 was studied. 
It has been shown that POC5 gets recruited to centrosome during 
G2/M and is involved in centriole elongation (Azimzadeh, Hergert 
et al. 2009). This protein has a similar cell cycle pattern to CEP78. 
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So we first studied the effect of CEP78 overexpression on the 
number of POC5 dots. Our results showed that the overexpression 
had no significant effect on the number of POC5 dots and most 
transfected cells showed similar results to the control. One 
possible explanation could be that CEP78 is downstream to POC5 
hence does not affect POC5. Therefore, it would be a good idea to 
study the effect of POC5 overexpression/depletion on the number 
of CEP78 dots as well. Moreover, in the research on POC5, the 
distance between the distal ends of the mother and daughter 
centrioles was measured to study the effect of POC5 depletion on 
centriole elongation by high resolution microscopy. It would be 
interesting to measure this distance following CEP78 
overexpression/knockdown as well. POC5 is a distal centriolar 
protein which colocalizes quite well with CEP78. So for the next 
step, the interaction between CEP78 and POC5 was studied in 293 
cells using immunoprecipitation. Despite what we expected, no 
interaction was observed between the two proteins. There are 
other proteins involved in centriole maturation as well including 
PLK1. This protein plays a role in centriole maturation by 
recruitment of Aurora A to the centrosome (Korzeniewski, 
Hohenfellner et al. 2013). This persuaded us to study the possible 
interaction between this protein and CEP78 in 293 cells as well. 
However, our studies did not show an interaction between CEP78 
and PLK1. So far, our results do not show a role for CEP78 in 
centriole maturation but more experiments need to be done to 
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confirm this result. For instance, it would be interesting to study 
the effect of PLK1 inhibition on the number of CEP78 dots. 
 
Structurally, CEP78 consists of 4-6 Leucin rich repeats (LRRs), 
amino acids 147-308, and one coiled coil domain, amino acids 
450-497. In order to study the importance and function of each of 
these domains, fragments with deletions in one or some of these 
domains were expressed in RPE cells and their expression 
patterns were more closely studied. Our results indicated that the 
LRRs are essential for CEP78 localization to centrosome and any 
deletions in them would prevent the protein from its centrosomal 
localization. This could be due to an unidentified protein that 
binds to the LRRs of Cep78 and brings Cep78 to the centrosome. 
In order to identify this protein a mass-spectrometry analysis can 
be done to study the possible proteins interacting with CEP78. As 
for the coiled-coil domain, since these domains are usually 
involved in the regulation of gene expression, CEP78 coiled-coil 
domain might play a similar role in its expression level as well. 
 
Overexpression of full length CEP78 and the CEP78 fragments 
containing the three middle LRRs in RPE cells showed a 
microtubule binding pattern. To further study this phenotype and 
the effect of CEP78 overexpression on microtubule stability and 
nucleation, both RPE and ARPE cells were transfected with full 
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length CEP78 and then treated with Nocodazole. Contrary to what 
we expected, the transfected cells maintained their microtubule 
network even after the depolymerizing treatment. One 
explanation for this phenotype could be that CEP78 when 
overexpressed, covers microtubules and does not allow 
nocodazole to depolymerize them. Also, carrying out this 
experiment for CEP78 fragments showed that the fragments 
containing the three middle LRRs, amino acids 221-445, had the 
ability to stabilize microtubules as well.  It seems that the region 
responsible for this phenotype is somewhere in the three middle 
LRRs but still more fragments are necessary to identify the exact 
region involved in this phenotype. The next question to answer 
ǁas ǁhether CEPϳϴ staďilized ŵiĐrotuďules ďǇ ďiŶdiŶg α-tubulin 
directly. For this purpose, full length CEP78 was expressed in 293 
cells and immunoprecipitation assay was carried out. Western for 
α-tuďuliŶ did Ŷot shoǁ aŶ iŶteraĐtioŶ ďetǁeeŶ CEPϳϴ aŶd α-
tubulin. However, it is possible that CEP78 interacts with 
microtubules that are polymers of tubulins instead and therefore 
further studies are necessary to confirm the microtubule binding 
activity of CEP78 by an in vitro microtubule binding assay. 
 
IŶ a ŵeetiŶg held oŶ ͞BuildiŶg a CeŶtrosoŵe͟ iŶ ϮϬϭϯ, it ǁas 
suggested that CEP78 interacts with PLK4, CP110 and CEP97 
(Baffet, Martin et al. 2013).  These proteins are involved in 
centriole duplication and cooperate to regulate this process. In 
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order to study the possible role of CEP78 in centriole duplication 
or accumulation, several centriolar proteins including CEP164 
(mother centriole marker), SA6 (procentriole marker) and Centrin 
(mother, daughter and procentriole marker) were studied after 
overexpressing CEP78 in RPE cells. Our results indicated no 
increase/ decrease in the number of centrioles and the number of 
mother, daughter or procentrioles did not change. This suggests 
that CEP78 overexpression does not result in centriole 
overduplication or accumulation. Also, there is no significant 
change in the number or intensity of CEP78 dots at S phase  
during which the centriole duplication occurs.  
 
Studying the effect of CEP78 overexpression on various 
centrosomal components in RPE cells showed that the only 
affected protein was CEP170 which is a sub-distal appendage 
protein. This protein localizes only to the mother centriole and its 
overexpression shows a microtubule binding pattern similar to 
CEP78 (Guarguaglini, Duncan et al. 2005). The results of our 
overexpression studies indicated that the RPE cells expressing full 
length CEP78 did not have CEP170 or the intensity of this protein 
was too weak in them. Despite the observed phenotype, the 
expression level of CEP170 did not decrease in 293 cells 
overexpressing full length CEP78. This could mean that CEP78 
does not regulate the expression of CEP170 but instead might 
play a role in its recruitment to the centrosome. This could be due 
  90 
to cell line-specific differences as well so it would be a good idea  
to study the effect of CEP78 overexpression on the number and 
expression level of CEP170 in other cell lines. We were also 
curious to see if this phenotype is caused by the direct interaction 
of CEP78 and CEP170. For this purpose, the interaction between 
CEP78 and CEP170 was studied by co-immunoprecipitation and 
contrary to what we expected no interaction was observed  
between the two proteins. Next, we looked at the effect of CEP78 
overexpression on another sub-distal appendage marker, Ninein. 
Unlike CEP170, there was no decrease in the number of Ninein 
dots in RPE cells overexpressing full length CEP78. Furthermore, 
there was no interaction between CEP78 and Ninein in 293 cells 
overexpressing full length CEP78. For future direction, it would be 
interesting to study more sub-distal appendage proteins as well as 
the effect of their overexpression on the number of CEP78 dots 
and determine whether Cep78 plays a role in the 
formation/maintenance of sub-distal appendages, a hallmark of 
centrosome maturation. 
 
As it was mentioned before, it is important to study the function 
of novel centrosomal proteins in order to use this information for 
possible therapeutic applications in the future. As for the clinical 
studies on CEP78, there have been very few papers published so 
far. In 2007, a study was carried out by Nesslinger et al. on the 
effect of standard treatments, hormone and radiation therapy, on 
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immune responses in prostate cancer patients (Nesslinger, Sahota 
et al. 2007). They used SEREX immunoscreening of a prostate 
cancer cDNA expression library and discovered several treatment 
associated autoanitigens including CEP78. In their SEREX antigen 
array analysis, CEP78 was negative in the pretreatment sample 
but was seroreactive following hormone therapy. This could imply 
the possible importance of CEP78 in prostate cancer. All our 
studies were carried in RPE, ARPE and 293 cells. For future 
direction, it would be a good idea to use a prostate cancer cell line 
as well to study CEP78 overexpression pattern and its possible 
phenotype. Also, comparing the mRNA/protein levels of Cep78 in 
a prostate cell line and other cell lines would be interesting. 
Finally, it is a good idea to study the effect of CEP78 knockdown in 
a prostate cell line and see if these cells stop growing. 
Finally, there are two studies suggesting a possible role for CEP78 
in ciliogenesis. In a study on the components of the human 
centrosome for which homologs are still present in planarians, 
Azimzadeh et al.  observed a locomotion defect in planarians 
knocked down for CEP78 (Azimzadeh, Wong et al. 2012). Since 
planarians lack centrosomes but still own cilia, it is suggested that 
CEP78 is rather involved in ciliogenesis. In another study, it was 
observed that CEP78 expression is upregulated 5 fold by noise 
stress in rat cochleae (Han, Hong et al. 2012). A possible 
explanation could be the effect it has on the cochleae cilia. 
Although our preliminary experiments did not show any change in 
the number of cilia following CEP78 overexpression, further 
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studies including knocking down CEP78 are still necessary to 
confirm these results.  
 
In order to confirm the results of the overexpression studies 
including the observed decrease in CEP170, the knockdown of 
CEP78 was required. For this, several siRNA oligos, transfection 
reagents and incubation times were used but none was efficient. 
Previously, Azimzadeh et al. used a double knockdown procedure 
to knock down CEP78 (Azimzadeh, Wong et al. 2012). Although 
we used the same oligos and procedure, the knockdown was not 
as good as we expected. For future direction, it would be a good 
option to use shRNA for CEP78 knockdown. The advantage of 
using shRNA is that its effect can be more specific and last longer 
than siRNA. 
 
In summary, I found that CEP78 decreases the number and 
intensity of CEP170 and it helps stabilize the microtubule network 
in RPE cells treated with nocodazole. My findings contribute to 
our understanding of the role of centrosome in the cell cycle and 
cytoskeleton. 
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